TNFSF10 and neoplasm: Accordingly, and as assessed by methylene blue, combined treatments in HCT116 and MDA-MB-231 cells lines with varying concentration of TRAIL and mAbs for 16 h revealed that 4 out of the 9 mAbs were able to synergize with TRAIL to inhibit the cell viability of these tumour cell lines (Fig. 4).